INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $321,297 | -91.3% | 6,444 | -90.6% | 0.00% | -100.0% |
Q2 2022 | $3,696,000 | -59.3% | 68,437 | -44.4% | 0.00% | -50.0% |
Q1 2022 | $9,084,000 | +84.7% | 123,165 | +212.9% | 0.00% | +33.3% |
Q4 2021 | $4,917,000 | -16.0% | 39,361 | -7.2% | 0.00% | 0.0% |
Q3 2021 | $5,853,000 | +1642.0% | 42,423 | +1818.7% | 0.00% | – |
Q2 2021 | $336,000 | +63.1% | 2,211 | -21.5% | 0.00% | – |
Q1 2021 | $206,000 | -67.3% | 2,817 | -67.5% | 0.00% | – |
Q4 2020 | $630,000 | +1025.0% | 8,656 | +221.5% | 0.00% | – |
Q3 2020 | $56,000 | -84.0% | 2,692 | -81.1% | 0.00% | – |
Q2 2020 | $350,000 | +11566.7% | 14,268 | +5408.9% | 0.00% | – |
Q1 2020 | $3,000 | -96.1% | 259 | -95.1% | 0.00% | – |
Q4 2019 | $77,000 | +48.1% | 5,258 | +32.8% | 0.00% | – |
Q3 2019 | $52,000 | -17.5% | 3,958 | +3.5% | 0.00% | – |
Q2 2019 | $63,000 | +384.6% | 3,824 | +406.5% | 0.00% | – |
Q1 2019 | $13,000 | +116.7% | 755 | +61.3% | 0.00% | – |
Q4 2018 | $6,000 | -80.0% | 468 | -54.5% | 0.00% | – |
Q3 2018 | $30,000 | +7.1% | 1,029 | -0.7% | 0.00% | – |
Q2 2018 | $28,000 | +366.7% | 1,036 | +245.3% | 0.00% | – |
Q1 2018 | $6,000 | -76.0% | 300 | -76.9% | 0.00% | – |
Q4 2017 | $25,000 | -83.9% | 1,300 | -79.3% | 0.00% | – |
Q3 2017 | $155,000 | +22.0% | 6,284 | -20.7% | 0.00% | – |
Q2 2017 | $127,000 | +1170.0% | 7,922 | +1031.7% | 0.00% | – |
Q1 2017 | $10,000 | -16.7% | 700 | -9.4% | 0.00% | – |
Q4 2016 | $12,000 | 0.0% | 773 | +10.4% | 0.00% | – |
Q3 2016 | $12,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |